[Gln22] - beta - Amyloid (1 - 40), Dutch Mutation
| Name | [Gln22] - beta - Amyloid (1 - 40), Dutch Mutation |
| Category | Beta-Amyloidand Related Peptides |
| One Letter Code | DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV |
| Three Letter Code | {Asp}{Ala}{Glu}{Phe}{Arg}{His}{Asp}{Ser}{Gly}{Tyr}{Glu}{Val}{His}{His}{Gln}{Lys}{Leu}{Val}{Phe}{Phe}{Ala}{Gln}{Asp}{Val}{Gly}{Ser}{Asn}{Lys}{Gly}{Ala}{Ile}{Ile}{Gly}{Leu}{Met}{Val}{Gly}{Gly}{Val}{Val} |
| Molecular Weight | 4328.900 |
| Application | Alzheimer's Disease |
| Jan, Asad, Dean M. Hartley, and Hilal A. Lashuel. "Preparation and characterization of toxic Aβ aggregates for structural and functional studies in Alzheimer's disease research." Nature protocols 5.6 (2010): 1186. |
| Solito, Raffaella, et al. "Dutch and arctic mutant peptides of β amyloid1–40 differentially affect the FGF-2 pathway in brain endothelium." Experimental cell research 315.3 (2009): 385-395. |
| Muñoz, Francisco J., et al. "Vitamin E but not 17β-estradiol protects against vascular toxicity induced by β-amyloid wild type and the Dutch amyloid variant." Journal of Neuroscience 22.8 (2002): 3081-3089. |
| Kumar-Singh, Samir, et al. "In vitro studies of Flemish, Dutch, and wild-type β-amyloid provide evidence for two-staged neurotoxicity." Neurobiology of disease 11.2 (2002): 330-340. |
| Sian, Aneet K., et al. "Oligomerization of β-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types." Biochemical Journal 349.1 (2000): 299-308. |
| Miravalle, Leticia, et al. "Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells." Journal of Biological Chemistry 275.35 (2000): 27110-27116. |
| Wang, Zhenzhen, et al. "Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid b proteins to human cerebral microvessel and aortic smooth muscle cells." Stroke 31.2 (2000): 534-8. |